Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pickar

Showing results (221-230 of 268) with videos related to

Pageof 27
Sort By:
Psychiatry Research|September 1, 1980
Presynaptic noradrenergic regulation during depression and antidepressant drug treatmentR M Cohen, I C Campbell, M R Cohen, et al.
Electroencephalography and Clinical Neurophysiology|September 1, 1994
Spectrum of EEG abnormalities during clozapine treatmentB A Malow, K B Reese, S Sato, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 1999
Mechanism of peripheral noradrenergic stimulation by clozapineI Elman, D S Goldstein, G Eisenhofer, et al.
Synapse (New York, N.Y.)|May 21, 1998
Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approachA Breier, C M Adler, N Weisenfeld, et al.
Archives of General Psychiatry|August 1, 1993
Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenicsJ K Hsiao, J Colison, J J Bartko, et al.
Psychiatry Research|September 11, 1999
In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapineT J Raedler, M B Knable, T Lafargue, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1989
Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophreniaR M Cohen, W E Semple, M Gross, et al.
Journal of Neural Transmission. Supplementum|June 13, 1998
Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline)D L Murphy, F Karoum, D Pickar, et al.
Archives of General Psychiatry|August 1, 1993
Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophreniaR R Owen, R Gutierrez-Esteinou, J Hsiao, et al.
The American Journal of Psychiatry|March 1, 1996
Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot studyD G Daniel, T E Goldberg, D R Weinberger, et al.
Pageof 27

Showing results (221-230 of 268) with videos related to

Sort By:
Pageof 27
Psychiatry Research|September 1, 1980
Presynaptic noradrenergic regulation during depression and antidepressant drug treatmentR M Cohen, I C Campbell, M R Cohen, et al.
Electroencephalography and Clinical Neurophysiology|September 1, 1994
Spectrum of EEG abnormalities during clozapine treatmentB A Malow, K B Reese, S Sato, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 1999
Mechanism of peripheral noradrenergic stimulation by clozapineI Elman, D S Goldstein, G Eisenhofer, et al.
Synapse (New York, N.Y.)|May 21, 1998
Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approachA Breier, C M Adler, N Weisenfeld, et al.
Archives of General Psychiatry|August 1, 1993
Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenicsJ K Hsiao, J Colison, J J Bartko, et al.
Psychiatry Research|September 11, 1999
In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapineT J Raedler, M B Knable, T Lafargue, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1989
Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophreniaR M Cohen, W E Semple, M Gross, et al.
Journal of Neural Transmission. Supplementum|June 13, 1998
Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline)D L Murphy, F Karoum, D Pickar, et al.
Archives of General Psychiatry|August 1, 1993
Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophreniaR R Owen, R Gutierrez-Esteinou, J Hsiao, et al.
The American Journal of Psychiatry|March 1, 1996
Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot studyD G Daniel, T E Goldberg, D R Weinberger, et al.
Pageof 27